254 related articles for article (PubMed ID: 34601000)
1. J2N-k hamster model simulates severe infection caused by severe acute respiratory syndrome coronavirus 2 in patients with cardiovascular diseases.
Lee H; Lee TY; Jeon P; Kim N; Kim JW; Yang JS; Kim KC; Lee JY
J Virol Methods; 2022 Jan; 299():114306. PubMed ID: 34601000
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyopathy Does Not Exacerbate the Severity of Pneumonia Caused by a SARS-CoV-2 Delta Variant in the J2N-k Hamster Model.
Iwatsuki-Horimoto K; Ito M; Okuda-Hamabata M; Takagi H; Imai M; Kawaoka Y
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140522
[TBL] [Abstract][Full Text] [Related]
3. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model.
Dhakal S; Ruiz-Bedoya CA; Zhou R; Creisher PS; Villano JS; Littlefield K; Ruelas Castillo J; Marinho P; Jedlicka AE; Ordonez AA; Bahr M; Majewska N; Betenbaugh MJ; Flavahan K; Mueller ARL; Looney MM; Quijada D; Mota F; Beck SE; Brockhurst J; Braxton AM; Castell N; Stover M; D'Alessio FR; Metcalf Pate KA; Karakousis PC; Mankowski JL; Pekosz A; Jain SK; Klein SL;
mBio; 2021 Aug; 12(4):e0097421. PubMed ID: 34253053
[TBL] [Abstract][Full Text] [Related]
4. Modeling SARS-CoV-2: Comparative Pathology in Rhesus Macaque and Golden Syrian Hamster Models.
Choudhary S; Kanevsky I; Yildiz S; Sellers RS; Swanson KA; Franks T; Rathnasinghe R; Munoz-Moreno R; Jangra S; Gonzalez O; Meade P; Coskran T; Qian J; Lanz TA; Johnson JG; Tierney CA; Smith JD; Tompkins K; Illenberger A; Corts P; Ciolino T; Dormitzer PR; Dick EJ; Shivanna V; Hall-Ursone S; Cole J; Kaushal D; Fontenot JA; Martinez-Romero C; McMahon M; Krammer F; Schotsaert M; García-Sastre A
Toxicol Pathol; 2022 Apr; 50(3):280-293. PubMed ID: 35128980
[TBL] [Abstract][Full Text] [Related]
5. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19.
Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR
Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799
[TBL] [Abstract][Full Text] [Related]
6. Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters.
Brocato RL; Principe LM; Kim RK; Zeng X; Williams JA; Liu Y; Li R; Smith JM; Golden JW; Gangemi D; Youssef S; Wang Z; Glanville J; Hooper JW
J Virol; 2020 Oct; 94(22):. PubMed ID: 32900822
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the pathogenesis of SARS-CoV-2 infection in K18-hACE2 mouse and Syrian golden hamster models.
Jeong H; Woo Lee Y; Park IH; Noh H; Kim SH; Kim J; Jeon D; Jang HJ; Oh J; On D; Uhm C; Cho K; Oh H; Yoon S; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Yeon Kim S; Kim YB; Hwang JY; Lee HJ; Kim HB; Jeong DG; Song D; Song M; Park MS; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Nam KT; Seong JK
Dis Model Mech; 2022 Nov; 15(11):. PubMed ID: 36222118
[TBL] [Abstract][Full Text] [Related]
8. Compellingly high SARS-CoV-2 susceptibility of Golden Syrian hamsters suggests multiple zoonotic infections of pet hamsters during the COVID-19 pandemic.
Blaurock C; Breithaupt A; Weber S; Wylezich C; Keller M; Mohl BP; Görlich D; Groschup MH; Sadeghi B; Höper D; Mettenleiter TC; Balkema-Buschmann A
Sci Rep; 2022 Sep; 12(1):15069. PubMed ID: 36064749
[TBL] [Abstract][Full Text] [Related]
9. Syrian hamsters as a model of lung injury with SARS-CoV-2 infection: Pathologic, physiologic, and detailed molecular profiling.
Bednash JS; Kagan VE; Englert JA; Farkas D; Tyurina YY; Tyurin VA; Samovich SN; Farkas L; Elhance A; Johns F; Lee H; Cheng L; Majumdar A; Jones D; Mejia OR; Ruane-Foster M; Londino JD; Mallampalli RK; Robinson RT
Transl Res; 2022 Feb; 240():1-16. PubMed ID: 34740873
[TBL] [Abstract][Full Text] [Related]
10. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.
Imai M; Iwatsuki-Horimoto K; Hatta M; Loeber S; Halfmann PJ; Nakajima N; Watanabe T; Ujie M; Takahashi K; Ito M; Yamada S; Fan S; Chiba S; Kuroda M; Guan L; Takada K; Armbrust T; Balogh A; Furusawa Y; Okuda M; Ueki H; Yasuhara A; Sakai-Tagawa Y; Lopes TJS; Kiso M; Yamayoshi S; Kinoshita N; Ohmagari N; Hattori SI; Takeda M; Mitsuya H; Krammer F; Suzuki T; Kawaoka Y
Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16587-16595. PubMed ID: 32571934
[TBL] [Abstract][Full Text] [Related]
11. Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model.
Li C; Chen YX; Liu FF; Lee AC; Zhao Y; Ye ZH; Cai JP; Chu H; Zhang RQ; Chan KH; Chiu KH; Lung DC; Sridhar S; Hung IF; To KK; Zhang AJ; Chan JF; Yuen KY
Clin Infect Dis; 2021 Aug; 73(3):e719-e734. PubMed ID: 33515458
[TBL] [Abstract][Full Text] [Related]
12. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.
Zhang AJ; Lee AC; Chan JF; Liu F; Li C; Chen Y; Chu H; Lau SY; Wang P; Chan CC; Poon VK; Yuan S; To KK; Chen H; Yuen KY
Clin Infect Dis; 2021 Jun; 72(12):e978-e992. PubMed ID: 33216851
[TBL] [Abstract][Full Text] [Related]
13. Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters.
Roberts A; Thomas WD; Guarner J; Lamirande EW; Babcock GJ; Greenough TC; Vogel L; Hayes N; Sullivan JL; Zaki S; Subbarao K; Ambrosino DM
J Infect Dis; 2006 Mar; 193(5):685-92. PubMed ID: 16453264
[TBL] [Abstract][Full Text] [Related]
14. [Clinical symptoms and signs in hamsters during experimental infection with the SARS-CoV-2 virus (Coronaviridae:
Tuyskanova MS; Zhugunissov KD; Ozaslan M; Myrzakhmetova BS; Kutumbetov LB
Vopr Virusol; 2023 Dec; 68(6):513-525. PubMed ID: 38156567
[TBL] [Abstract][Full Text] [Related]
15. Surgical Mask Partition Reduces the Risk of Noncontact Transmission in a Golden Syrian Hamster Model for Coronavirus Disease 2019 (COVID-19).
Chan JF; Yuan S; Zhang AJ; Poon VK; Chan CC; Lee AC; Fan Z; Li C; Liang R; Cao J; Tang K; Luo C; Cheng VC; Cai JP; Chu H; Chan KH; To KK; Sridhar S; Yuen KY
Clin Infect Dis; 2020 Nov; 71(16):2139-2149. PubMed ID: 32472679
[TBL] [Abstract][Full Text] [Related]
16. Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection.
Rizvi ZA; Dalal R; Sadhu S; Binayke A; Dandotiya J; Kumar Y; Shrivastava T; Gupta SK; Aggarwal S; Tripathy MR; Rathore DK; Yadav AK; Medigeshi GR; Pandey AK; Samal S; Asthana S; Awasthi A
Elife; 2022 Jan; 11():. PubMed ID: 35014610
[TBL] [Abstract][Full Text] [Related]
17. Severe Acute Respiratory Syndrome Coronavirus 2 Vasculopathy in a Syrian Golden Hamster Model.
Ball EE; Weiss CM; Liu H; Jackson K; Keel MK; Miller CJ; Van Rompay KKA; Coffey LL; Pesavento PA
Am J Pathol; 2023 Jun; 193(6):690-701. PubMed ID: 36906263
[TBL] [Abstract][Full Text] [Related]
18. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters.
Roberts A; Vogel L; Guarner J; Hayes N; Murphy B; Zaki S; Subbarao K
J Virol; 2005 Jan; 79(1):503-11. PubMed ID: 15596843
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Variant Pathogenesis Following Primary Infection and Reinfection in Syrian Hamsters.
Plunkard J; Mulka K; Zhou R; Tarwater P; Zhong W; Lowman M; Wong A; Pekosz A; Villano J
mBio; 2023 Apr; 14(2):e0007823. PubMed ID: 37036339
[TBL] [Abstract][Full Text] [Related]
20. Design and validation of an exposure system for efficient inter-animal SARS-CoV-2 airborne transmission in Syrian hamsters.
Kuehl PJ; Dearing J; Werts A; Cox J; Irshad H; Barrett EG; Tucker SN; Langel SN
Microbiol Spectr; 2023 Dec; 11(6):e0471722. PubMed ID: 37882564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
